M. Benekli Et Al. , "Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma," BONE MARROW TRANSPLANTATION , vol.41, no.7, pp.613-619, 2008
Benekli, M. Et Al. 2008. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma. BONE MARROW TRANSPLANTATION , vol.41, no.7 , 613-619.
Benekli, M., Smiley, S. L., Younis, T., Czuczman, M. S., Hernandez-Ilizaliturri, F., Bambach, B., ... Battiwalla, M.(2008). Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma. BONE MARROW TRANSPLANTATION , vol.41, no.7, 613-619.
Benekli, M. Et Al. "Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma," BONE MARROW TRANSPLANTATION , vol.41, no.7, 613-619, 2008
Benekli, M. Et Al. "Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma." BONE MARROW TRANSPLANTATION , vol.41, no.7, pp.613-619, 2008
Benekli, M. Et Al. (2008) . "Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma." BONE MARROW TRANSPLANTATION , vol.41, no.7, pp.613-619.
@article{article, author={M. Benekli Et Al. }, title={Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma}, journal={BONE MARROW TRANSPLANTATION}, year=2008, pages={613-619} }